scholarly article | Q13442814 |
P50 | author | Temugin Berta | Q56998987 |
Yong-Jing Gao | Q42386001 | ||
Ru-Rong Ji | Q42386007 | ||
P2093 | author name string | Xin Zhang | |
Zhi-Jun Zhang | |||
Bao-Chun Jiang | |||
Li-Na He | |||
De-Li Cao | |||
Xiao-Bo Wu | |||
Wen-Wen Zhang | |||
Chun-Hua Li | |||
P2860 | cites work | MicroRNAs: target recognition and regulatory functions | Q24609584 |
Chemokines and the pathophysiology of neuropathic pain | Q24683873 | ||
Critical role of connexin 43 in secondary expansion of traumatic spinal cord injury | Q27863423 | ||
A chemokine-driven positive feedback loop organizes lymphoid follicles | Q28142202 | ||
P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury | Q28201682 | ||
Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21 | Q28240813 | ||
Induction of the P2X7 receptor in spinal microglia in a neuropathic pain model | Q28248260 | ||
A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen | Q28300225 | ||
Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 | Q28505948 | ||
Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia | Q28573077 | ||
BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain | Q29616106 | ||
The many roles of chemokines and chemokine receptors in inflammation | Q29618880 | ||
CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy. | Q30480341 | ||
MAP kinase and pain | Q30482277 | ||
Chemokines in the CNS: plurifunctional mediators in diverse states | Q33756119 | ||
An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat | Q34239178 | ||
Central sensitization and LTP: do pain and memory share similar mechanisms? | Q34277624 | ||
Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2. | Q34325096 | ||
The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries | Q34579481 | ||
TRAF6 upregulation in spinal astrocytes maintains neuropathic pain by integrating TNF-α and IL-1β signaling | Q34603534 | ||
Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. | Q54785181 | ||
Expression of CCR2 in Both Resident and Bone Marrow-Derived Microglia Plays a Critical Role in Neuropathic Pain | Q56886107 | ||
Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury | Q56886108 | ||
Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice | Q57898584 | ||
ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model | Q57990428 | ||
miR-186, miR-3651 and miR-494: Potential biomarkers for oral squamous cell carcinoma extracted from whole blood | Q58601868 | ||
Pronociceptive actions of dynorphin maintain chronic neuropathic pain | Q73550448 | ||
Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections | Q80482511 | ||
CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis | Q80880885 | ||
Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain | Q81919054 | ||
CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis | Q83918246 | ||
Spinal astrocytic activation contributes to mechanical allodynia in a mouse model of type 2 diabetes | Q95824849 | ||
Spinal astrocytic activation contributes to mechanical allodynia in a rat chemotherapy-induced neuropathic pain model | Q34667811 | ||
MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript | Q34804590 | ||
The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system | Q35104199 | ||
Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of Paclitaxel-induced painful neuropathy | Q35803293 | ||
Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells | Q36368917 | ||
Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord | Q36691900 | ||
Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis | Q36943086 | ||
Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce? | Q36963161 | ||
Tissue plasminogen activator contributes to morphine tolerance and induces mechanical allodynia via astrocytic IL-1β and ERK signaling in the spinal cord of mice | Q37042958 | ||
JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain | Q37194288 | ||
Possible role of glial cells in the onset and progression of Lyme neuroborreliosis | Q37356125 | ||
Glia and pain: is chronic pain a gliopathy? | Q37381399 | ||
Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons | Q37507494 | ||
Extracellular caspase-6 drives murine inflammatory pain via microglial TNF-α secretion | Q37602200 | ||
Chemokines and cytokines in neuroinflammation leading to neuropathic pain | Q37948466 | ||
Chemokine mediated neuron-glia communication and aberrant signalling in neuropathic pain states | Q37953080 | ||
Extracellular microRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1 | Q38689759 | ||
miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. | Q38928705 | ||
Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain | Q39323926 | ||
The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis | Q40414775 | ||
Spinal injection of TNF-α-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1 | Q42150441 | ||
miR-7a alleviates the maintenance of neuropathic pain through regulation of neuronal excitability. | Q42283334 | ||
Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions | Q42466912 | ||
Leptin enhances NMDA-induced spinal excitation in rats: A functional link between adipocytokine and neuropathic pain | Q42736961 | ||
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. | Q43227358 | ||
CXCL13 and CXCL12 in central nervous system lymphoma patients. | Q43272851 | ||
P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain | Q43917782 | ||
The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore | Q46074716 | ||
Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. | Q47249503 | ||
Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain | Q47599610 | ||
Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain | Q48187325 | ||
Evidence for activation of astrocytes via reactive microglial cells following hypoglossal nerve transection. | Q48255668 | ||
ERK integrates PKA and PKC signaling in superficial dorsal horn neurons. I. Modulation of A-type K+ currents | Q48308492 | ||
Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma | Q48462130 | ||
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment | Q48701331 | ||
Spinal P2X(7) receptor mediates microglia activation-induced neuropathic pain in the sciatic nerve injury rat model | Q48888346 | ||
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | astrocyte | Q502961 |
neuropathic pain | Q2798704 | ||
P304 | page(s) | 745-761 | |
P577 | publication date | 2016-01-11 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5. | |
P478 | volume | 126 |
Q44340800 | Altered expression of glial markers, chemokines, and opioid receptors in the spinal cord of type 2 diabetic monkeys |
Q92392859 | Association of circulating microRNAs with prevalent and incident knee osteoarthritis in women: the OFELY study |
Q90183678 | Astrocytes in chronic pain and itch |
Q92900028 | CXCL12/CXCR4 signaling contributes to neuropathic pain via central sensitization mechanisms in a rat spinal nerve ligation model |
Q37314840 | CXCL13/CXCR5 enhances sodium channel Nav1.8 current density via p38 MAP kinase in primary sensory neurons following inflammatory pain |
Q37350039 | Cerebrospinal fluid cytokines in Lyme neuroborreliosis. |
Q38982684 | Chemokine CXCL13 activates p38 MAPK in the trigeminal ganglion after infraorbital nerve injury. |
Q37084908 | Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of mice |
Q38841148 | Chemokine Receptor CXCR3 in the Spinal Cord Contributes to Chronic Itch in Mice |
Q89545828 | Chemokine receptor CCR2 contributes to neuropathic pain and the associated depression via increasing NR2B-mediated currents in both D1 and D2 dopamine receptor-containing medium spiny neurons in the nucleus accumbens shell |
Q39227824 | Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain. |
Q92352882 | Contribution of spinal cord glial cells to L. amazonensis experimental infection-induced pain in BALB/c mice |
Q58104642 | Demethylation of G protein-coupled receptor 151 promoter facilitates the binding of Kruppel-like factor 5 and enhances neuropathic pain after nerve injury in mice |
Q92535035 | Developing Modern Pain Therapies |
Q50426470 | Divergent roles of immune cells and their mediators in pain |
Q47438502 | Downregulation of spinal astrocytic connexin43 leads to upregulation of interleukin-6 and cyclooxygenase-2 and mechanical hypersensitivity in mice. |
Q89948288 | Identification of significant gene biomarkers of low back pain caused by changes in the osmotic pressure of nucleus pulposus cells |
Q37640194 | Interleukin-1β pre-treated bone marrow stromal cells alleviate neuropathic pain through CCL7-mediated inhibition of microglial activation in the spinal cord. |
Q53410445 | Lipopolysaccharide from Rhodobacter sphaeroides (TLR4 antagonist) attenuates hypersensitivity and modulates nociceptive factors. |
Q36783527 | Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection |
Q96953382 | Long-Term Continuous Cervical Spinal Cord Stimulation Exerts Neuroprotective Effects in Experimental Parkinson's Disease |
Q38702143 | MicroRNA-186-5p overexpression modulates colon cancer growth by repressing the expression of the FAM134B tumour inhibitor. |
Q90311754 | NLRP3 inflammasome signaling as an early molecular response is negatively controlled by miR-186 in CFA-induced prosopalgia mice |
Q52692785 | Neuroinflammation and Central Sensitization in Chronic and Widespread Pain. |
Q39255819 | Neuropathic Pain: Central vs. Peripheral Mechanisms |
Q33925526 | Neuropathic pain promotes adaptive changes in gene expression in brain networks involved in stress and depression |
Q64092590 | Ovarian Hormone-dependent and Spinal ERK Activation-regulated Nociceptive Hypersensitivity in Female Rats with Acid Injection-induced Chronic Widespread Muscle Pain |
Q92384478 | Pain and immunity: implications for host defence |
Q33846188 | Pain regulation by non-neuronal cells and inflammation |
Q48338246 | Promoted Interaction of C/EBPα with Demethylated Cxcr3 Gene Promoter Contributes to Neuropathic Pain in Mice |
Q97596208 | Protective role of neuronal and lymphoid cannabinoid CB2 receptors in neuropathic pain |
Q37577709 | Recent advances in understanding neuropathic pain: glia, sex differences, and epigenetics |
Q33772300 | Regulated Production of CXCL13 within the Central Nervous System |
Q93196709 | Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain |
Q98725953 | Sensory satellite glial Gq-GPCR activation alleviates inflammatory pain via peripheral adenosine 1 receptor activation |
Q48278436 | Spinal CCL2 Promotes Central Sensitization, Long-Term Potentiation, and Inflammatory Pain via CCR2: Further Insights into Molecular, Synaptic, and Cellular Mechanisms. |
Q55334164 | Spinal CXCL9 and CXCL11 are not involved in neuropathic pain despite an upregulation in the spinal cord following spinal nerve injury. |
Q93221565 | TLR8 and its endogenous ligand miR-21 contribute to neuropathic pain in murine DRG |
Q37039991 | TMEM16F Regulates Spinal Microglial Function in Neuropathic Pain States |
Q92094992 | TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells |
Q92243495 | The Anti-Inflammatory Effects of CXCR5 in the Mice Retina following Ischemia-Reperfusion Injury |
Q55315782 | The Regulatory Mechanisms and Therapeutic Potential of MicroRNAs: From Chronic Pain to Morphine Tolerance. |
Q39038441 | The therapeutic potential of targeting chemokine signalling in the treatment of chronic pain |
Q64119948 | Transcriptome profiling of dorsal root ganglia in a rat model of complex regional pain syndrome type-I reveals potential mechanisms involved in pain |
Q37481670 | Upregulation of (C-X-C motif) Ligand 13 (CXCL13) Attenuates Morphine Analgesia in Rats with Cancer-Induced Bone Pain |
Q33887632 | [EXPRESS] CXCL12/CXCR4 signaling mediated ERK1/2 activation in spinal cord contributes to the pathogenesis of postsurgical pain in rats |
Q92749961 | mGluR5/ERK signaling regulated the phosphorylation and function of glycine receptor α1ins subunit in spinal dorsal horn of mice |
Q47220985 | miR-23b Suppresses Leukocyte Migration and Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting CCL7. |
Q47828526 | miRNA-23a/CXCR4 regulates neuropathic pain via directly targeting TXNIP/NLRP3 inflammasome axis. |
Search more.